References
- Medscape expert Interview with Brinton EA. Statin Therapy: Risks vs Benefit. Medscape Cardiology. 2004; 8(1). Available from http://www.medscape.com.
- Cruz AC and Gruber BL. Statins and Osteoporosis: Can these lipid-lowering drugs also bolster bones? Cleveland Clin. J. of Medicine. 2002; 69(4).
- Gonyeau MJ. Statins and Osteoporosis: Clinical Review. J. Pharmacotherapy. 2005; 25(2): 228–243. Available from http://www.medscape.com.
- Bandolier Extra. Cholesterol and Statins. April 2004. Available from http://www.ebandolier.com.
- Tomlinson S and Mangione K. Potential Adverse Effects of Statins on Muscle. J. American Physical Therapy. May 2005; 85(5): 459–465.
- Fine DM. Statin-Related Muscle Toxicity. J. Clinical Pharmacology. November/December 2003; 3(10): 554–560.
- Missouri DUR Report. Statin Therapy. Drug Use Review Newsletter. October/November 2003; 8(6).
- Bottorff M, Hansten P. Long-term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors. Arch. Intern. Med. August 2000; 160.
- White MC. HMG CoA reductase inhibitor-induced muscle toxicity: risk, monitoring, and management. Formulary. November 2002; 37.
- Bauer DC. Update on the Skeletal effects of Statins. Available from http://www.medscape.com.
- Edwards CJ, et al. Statins and Bone: Myth or Reality? Calcif. Tissue. Int. July 2001; 69.
- Watts N. Bisphosphonates, Statins, Osteoporosis, and Atherosclerosis. July 2002. Available from http://www.medscape.com.
- Lupatelli G, et al. Simvastatin Increase Bone Mineral Density in Hypercholesterolaemia Postmenopausal Women. J. Metabolism. June 2004; 53(6): 744–748.
- Wang PS, et al. HMG-CoA Reductase Inhibitors and the Risk of Hip Fracture in Elderly Patients. JAMA. June 2000; 283(24): 3211–3216.